Possible risks to patients receiving statins combined with other medications [3]

Journal of the American College of Cardiology

Volumn 41, Issue 3, 2003, Pages 519-520

  Hansten, Philip D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATORVASTATIN; AZITHROMYCIN; CALCIUM CHANNEL BLOCKING AGENT; CLARITHROMYCIN; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; DILTIAZEM; DIRITHROMYCIN; ERYTHROMYCIN; FELODIPINE; FLUINDOSTATIN; ITRACONAZOLE; MACROLIDE; MEVINOLIN; NIFEDIPINE; PRAVASTATIN; SIMVASTATIN; STATINE DERIVATIVE; VERAPAMIL;

DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; LETTER; MYOPATHY; PRIORITY JOURNAL;

EID: 0037419862     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02815-2     Document Type: Letter

References (13)

1. Pasternak RC, Smith SC, Jr., Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002;40:567-72.
2. Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet 2002;41:343-70.
3. Neuvonen PJ, Jalava KM. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1996;60:54-61.
4. Neuvonen PJ, Kantola T, Kivistö KT. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Clin Pharmacol Ther 1998;63:332-41.
5. Kantola T, Kivistö KT, Neuvonen PJ. Effect of itraconazole on the pharmacokinetics of atorvastatin. Clin Pharmacol Ther 1998;64:58-65.
6. Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin. Clin Pharmacol Ther 2000;68:391-400.
7. Kantola T, Kivistö KT, Neuvonen P. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther 1998;64:177-82.
8. Lee AJ, Maddix DS. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. Ann Pharmacother 2001;35:26-31.
9. Watkins VS, Polk RE, Stotka JL. Drug interactions of macrolides: emphasis on dirithromycin. Ann Pharmacother 1997;31:349-56.
10. Azie NE, Brater C, Becker PA, Jones DR, Hall SD. The interaction of diltiazem with lovastatin and pravastatin. Clin Pharmacol Ther 1998;64:369-77.
11. Mousa O, Brater DC, Sunblad KJ, Hall SD. The interaction of diltiazem with simvastatin. Clin Pharmacol Ther 2000;67:267-74.
12. Peces R, Pobes A. Rhabdomyolysis associated with concurrent use of simvastatin and diltiazem. Nephron 2001;89:117-8.
13. Kanathur N, Mathai MG, Byrd RP, Jr., Fields CL, Roy TM. Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis. Tenn Med 2001;94:339-41.